Variable | n (%) | Univariate | Multivariate | ||
---|---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | ||
TINAGL1/COL1A1 | |||||
Others | 64 (85.3) | – | – | ||
TINAGL1 + /COL1A1 + | 11 (14.7) | 2.41 (1.09–5.28) | 0.029 | 3.78 (1.37–10.41) | 0.010 |
Age | |||||
> 65 | 31 (41.3) | – | – | ||
65 ≥ | 44 (58.7) | 0.80 (0.43–1.51) | 0.498 | 0.77 (0.36–1.68) | 0.516 |
Gender | |||||
Female | 39 (52.0) | – | – | ||
Male | 36 (48.0) | 1.55 (0.83–2.90) | 0.170 | 0.93 (0.45–1.94) | 0.845 |
Stage | |||||
I | 9 (12.0) | – | – | ||
II | 12 (16.0) | 7.98 (0.98–65.10) | 0.052 | 10.87 (1.24–95.02) | 0.031 |
III | 31 (41.3) | 9.49 (1.25–72.24) | 0.030 | 12.82 (1.57–104.51) | 0.017 |
IV | 23 (30.7) | 33.96 (4.36–264.71) | 0.001 | 57.30 (6.64–494.59) | < 0.001 |
Subtype | |||||
Metabolic | 16 (26.2) | – | – | ||
Proliferative | 12 (19.7) | 1.51 (0.54–4.20) | 0.427 | 0.72 (0.25–2.08) | 0.541 |
Mesenchymal | 33 (54.1) | 1.60 (0.71–3.63) | 0.256 | 0.98 (0.40–2.41) | 0.968 |